Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05132803
Title TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.